Search for: "MYLAN PHARMACEUTICALS INC."
Results 161 - 180
of 498
Sort by Relevance
|
Sort by Date
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
3 May 2016, 1:42 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
18 Apr 2016, 9:58 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
30 Mar 2016, 9:59 pm
Mylan Laboratories Ltd. et al. 1:15-cv-00942; filed October 19, 2015 in the District Court of Delaware • Plaintiffs: Fresenius Kabi USA, LLC; Fresenius Kabi Deutschland GmbH • Defendants: Mylan Laboratories Ltd.; Mylan Inc.; Agila Specialties Inc.; Mylan Pharmaceuticals Inc. [read post]
18 Mar 2016, 2:04 pm
Mylan Pharmaceuticals, Inc., 78 F. [read post]
17 Mar 2016, 2:45 am
Balkamp Inc., et al., No. 15-273 Arthrex, Inc. v. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
19 Feb 2016, 11:57 am
Isonas, Inc., 2014 WL 10988340 (C.D. [read post]
17 Feb 2016, 9:20 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Feb 2016, 8:57 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
1 Feb 2016, 10:43 am
Cir. 2012) (quotingAmgen Inc. v. [read post]
20 Jan 2016, 8:00 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
12 Jan 2016, 11:39 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
1 Jan 2016, 9:00 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
13 Nov 2015, 4:54 am
Mylan Inc., 840 F. [read post]
9 Nov 2015, 7:39 am
Merck Sharp & Dohme v Ono Pharmaceutical [2015] EWHC 2973 (Pat), decided on 22 October by Mr Justice Birss in the Patents Court, England and Wales, is a decidedly unbifurcated ruling, being a full-blooded infringement-and-invalidity action running to 243 paragraphs. [read post]
6 Nov 2015, 6:58 am
Mylan and Actavis were seeking revocation of the patent. [read post]